179 related articles for article (PubMed ID: 37221457)
1. Aprepitant inhibits the development and metastasis of gallbladder cancer via ROS and MAPK activation.
Cao X; Yang Y; Zhou W; Wang Y; Wang X; Ge X; Wang F; Zhou F; Deng X; Miao L
BMC Cancer; 2023 May; 23(1):471. PubMed ID: 37221457
[TBL] [Abstract][Full Text] [Related]
2. SP/NK-1R promotes gallbladder cancer cell proliferation and migration.
Deng XT; Tang SM; Wu PY; Li QP; Ge XX; Xu BM; Wang HS; Miao L
J Cell Mol Med; 2019 Dec; 23(12):7961-7973. PubMed ID: 30903649
[TBL] [Abstract][Full Text] [Related]
3. Antagonism of NK-1R using aprepitant suppresses inflammatory response in rheumatoid arthritis fibroblast-like synoviocytes.
Liu X; Zhu Y; Zheng W; Qian T; Wang H; Hou X
Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):1628-1634. PubMed ID: 31010320
[TBL] [Abstract][Full Text] [Related]
4. The NK-1R Antagonist Aprepitant Prevents LPS-Induced Oxidative Stress and Inflammation in RAW264.7 Macrophages.
Zhao XN; Bai ZZ; Li CH; Sheng CL; Li HY
Drug Des Devel Ther; 2020; 14():1943-1952. PubMed ID: 32546961
[TBL] [Abstract][Full Text] [Related]
5. Aprepitant Inhibits JNK and p38/MAPK to Attenuate Inflammation and Suppresses Inflammatory Pain.
Yang Y; Zhou W; Xu X; Ge X; Wang F; Zhang GQ; Miao L; Deng X
Front Pharmacol; 2021; 12():811584. PubMed ID: 35087409
[TBL] [Abstract][Full Text] [Related]
6. The Potential In Vitro Inhibitory Effects of Neurokinin-1 Receptor (NK-1R) Antagonist, Aprepitant, in Osteosarcoma Cell Migration and Metastasis.
Alsaeed MA; Ebrahimi S; Alalikhan A; Hashemi SF; Hashemy SI
Biomed Res Int; 2022; 2022():8082608. PubMed ID: 36177059
[TBL] [Abstract][Full Text] [Related]
7. Anti-proliferation and anti-inflammation effects of corilagin in rheumatoid arthritis by downregulating NF-κB and MAPK signaling pathways.
Shen Y; Teng L; Qu Y; Liu J; Zhu X; Chen S; Yang L; Huang Y; Song Q; Fu Q
J Ethnopharmacol; 2022 Feb; 284():114791. PubMed ID: 34737112
[TBL] [Abstract][Full Text] [Related]
8. Melatonin inhibits proliferation, migration, and invasion by inducing ROS-mediated apoptosis via suppression of the PI3K/Akt/mTOR signaling pathway in gallbladder cancer cells.
Chen K; Zhu P; Chen W; Luo K; Shi XJ; Zhai W
Aging (Albany NY); 2021 Sep; 13(18):22502-22515. PubMed ID: 34580235
[TBL] [Abstract][Full Text] [Related]
9. The SP/NK1R system promotes the proliferation of breast cancer cells through NF-κB-mediated inflammatory responses.
Jafarinezhad S; Assaran Darban R; Javid H; Hashemy SI
Cell Biochem Biophys; 2023 Dec; 81(4):787-794. PubMed ID: 37740877
[TBL] [Abstract][Full Text] [Related]
10. Neurokinin-1 receptor antagonist aprepitant regulates autophagy and apoptosis via ROS/JNK in intrahepatic cholangiocarcinoma.
Yang Y; Cao X; Wang Y; Wu X; Zhou P; Miao L; Deng X
Liver Int; 2024 Mar; ():. PubMed ID: 38554043
[TBL] [Abstract][Full Text] [Related]
11. Substance P accelerates the progression of human esophageal squamous cell carcinoma via MMP-2, MMP-9, VEGF-A, and VEGFR1 overexpression.
Mohammadi F; Javid H; Afshari AR; Mashkani B; Hashemy SI
Mol Biol Rep; 2020 Jun; 47(6):4263-4272. PubMed ID: 32436041
[TBL] [Abstract][Full Text] [Related]
12. The Neurokinin-1 Receptor Antagonist Aprepitant, a New Drug for the Treatment of Hematological Malignancies: Focus on Acute Myeloid Leukemia.
Muñoz M; Coveñas R
J Clin Med; 2020 Jun; 9(6):. PubMed ID: 32492831
[TBL] [Abstract][Full Text] [Related]
13. Effect of CLIC1 gene silencing on proliferation, migration, invasion and apoptosis of human gallbladder cancer cells.
He YM; Zhang ZL; Liu QY; Xiao YS; Wei L; Xi C; Nan X
J Cell Mol Med; 2018 May; 22(5):2569-2579. PubMed ID: 29516682
[TBL] [Abstract][Full Text] [Related]
14. Investigation of the Role of Neurokinin-1 Receptor Inhibition Using Aprepitant in the Apoptotic Cell Death through PI3K/Akt/NF-
Ghahremanloo A; Javid H; Afshari AR; Hashemy SI
Biomed Res Int; 2021; 2021():1383878. PubMed ID: 34395609
[TBL] [Abstract][Full Text] [Related]
15. The In Vitro Pro-inflammatory Functions of the SP/NK1R System in Prostate Cancer: a Focus on Nuclear Factor-Kappa B (NF-κB) and Its Pro-inflammatory Target Genes.
Ebrahimi S; Erfani B; Alalikhan A; Ghorbani H; Farzadnia M; Afshari AR; Mashkani B; Hashemy SI
Appl Biochem Biotechnol; 2023 Dec; 195(12):7796-7807. PubMed ID: 37093533
[TBL] [Abstract][Full Text] [Related]
16. The Repurposing of Non-Peptide Neurokinin-1 Receptor Antagonists as Antitumor Drugs: An Urgent Challenge for Aprepitant.
Coveñas R; Rodríguez FD; Robinson P; Muñoz M
Int J Mol Sci; 2023 Nov; 24(21):. PubMed ID: 37958914
[TBL] [Abstract][Full Text] [Related]
17. Tamoxifen inhibits cell proliferation by impaired glucose metabolism in gallbladder cancer.
Huang S; Wang H; Chen W; Zhan M; Xu S; Huang X; Lin R; Shen H; Wang J
J Cell Mol Med; 2020 Jan; 24(2):1599-1613. PubMed ID: 31782270
[TBL] [Abstract][Full Text] [Related]
18. Roles of Pin1 as a Key Molecule for EMT Induction by Activation of STAT3 and NF-κB in Human Gallbladder Cancer.
Nakada S; Kuboki S; Nojima H; Yoshitomi H; Furukawa K; Takayashiki T; Takano S; Miyazaki M; Ohtsuka M
Ann Surg Oncol; 2019 Mar; 26(3):907-917. PubMed ID: 30610554
[TBL] [Abstract][Full Text] [Related]
19. SLC25A22 promotes proliferation and metastasis by activating MAPK/ERK pathway in gallbladder cancer.
Du P; Liang H; Fu X; Wu P; Wang C; Chen H; Zheng B; Zhang J; Hu S; Zeng R; Liang B; Fang L
Cancer Cell Int; 2019; 19():33. PubMed ID: 30814911
[TBL] [Abstract][Full Text] [Related]
20. Combination Therapy of Chemotherapy or Radiotherapy and the Neurokinin-1 Receptor Antagonist Aprepitant: A New Antitumor Strategy?
Robinson P; Coveñas R; Muñoz M
Curr Med Chem; 2023; 30(16):1798-1812. PubMed ID: 35959620
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
